Tchaikapharma High Quality Medicines AD (BUL:THQM)

Market Cap	1.19B
Revenue (ttm)	53.14M
Net Income (ttm)	5.04M
Shares Out	91.80M
EPS (ttm)	0.05
PE Ratio	236.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,187
Average Volume	602
Open	10.00
Previous Close	n/a
Day's Range	10.00 - 13.00
52-Week Range	10.00 - 18.00
Beta	0.04
RSI	8.16
Earnings Date	Feb 25, 2025

About BUL:THQM

Tchaikapharma High Quality Medicines AD engages in the development and manufacture of generic and in-licensed medicines in Bulgaria. The company offers anaesthetic, anti-inflammatory and anti-rheumatic, antibiotic, cardiovascular system, digestive system, diabetes and metabolism, nervous system, OTC, respiratory system, oncology, and other medicines. It also provides nutritional supplements. The company was founded in 1999 and is headquartered in Sofia, Bulgaria.

• Industry: Pharmaceutical Preparations
• Founded: 1999
• Employees: 207
• Stock Exchange: Bulgarian Stock Exchange
• Ticker Symbol: THQM

Financial Performance

In 2024, BUL:THQM's revenue was 53.14 million, an increase of 9.54% compared to the previous year's 48.51 million. Earnings were 5.04 million, an increase of 48.26%.